ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,456Medicare Part D Prescriptions Filled, Including Refills

Rank: 265 out of 1107

$793K Total Retail Price of All Prescriptions

Rank: 169 out of 1107

580 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 580 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 580 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 7,859 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 413 280 1 2
OMEPRAZOLE 389 269 2 4
HYDROCODONE-ACETAMINOPHEN 389 179 S3 2 1
LEVOTHYROXINE SODIUM 380 250 4 3
SIMVASTATIN 320 273 5 5
AMLODIPINE BESYLATE 314 192 6 6
ATORVASTATIN CALCIUM 304 231 7 13
METOPROLOL SUCCINATE 301 257 8 16
ZOLPIDEM TARTRATE 255 174 9 22
HYDROCHLOROTHIAZIDE 251 162 10 11
METFORMIN HCL 231 175 11 8
WARFARIN SODIUM 189 173 12 15
METOPROLOL TARTRATE 178 158 13 10
DIOVAN 166 132 14 51
FUROSEMIDE 163 127 15 7
CRESTOR 153 112 16 23
POTASSIUM CHLORIDE 149 109 17 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 148 123 18 24
PANTOPRAZOLE SODIUM 124 99 19 30
FLUTICASONE PROPIONATE 115 86 20 38
GABAPENTIN 107 54 21 9
FENOFIBRATE 107 39 21 67
NEXIUM 100 43 23 18
AZITHROMYCIN 94 60 24 35
PROMETHAZINE HCL 93 22 R 25 44
CARVEDILOL 89 64 26 27
METHYLPREDNISOLONE 88 59 27 119
CELEBREX 84 73 28 85
BACLOFEN 82 37 29 133
TRICOR 81 57 30 95
SYNTHROID 80 61 31 70
CYMBALTA 77 37 32 50
SINGULAIR 75 19 33 65
SPIRIVA 74 36 34 57
DIOVAN HCT 71 71 35 106
VENLAFAXINE HCL ER 70 42 36 117
LIPITOR 70 55 36 109
VENTOLIN HFA 65 21 38 97
RANITIDINE HCL 63 39 39 21
PRAVASTATIN SODIUM 63 61 39 12
TRAZODONE HCL 62 21 41 33
MELOXICAM 61 33 42 25
IBUPROFEN 59 30 43 63
DOXAZOSIN MESYLATE 58 54 44 92
ACTOS 58 45 44 132
PROAIR HFA 57 26 46 37
GLIMEPIRIDE 57 47 46 43
CITALOPRAM HBR 57 20 46 17
TAMSULOSIN HCL 54 41 49 30
ATENOLOL 52 45 50 19
INSULIN SYRINGE 52 35 50 78
ENALAPRIL MALEATE 52 52 50 98
TRILIPIX 52 32 50 153
ISOSORBIDE MONONITRATE ER 52 52 50 34
ADVAIR DISKUS 51 30 55 54
KLOR-CON M20 50 48 56 75
CYCLOBENZAPRINE HCL 50 0 R 56 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.